Form 8-K - Current report:
SEC Accession No. 0000353569-19-000048
Filing Date
2019-08-08
Accepted
2019-08-08 16:24:06
Documents
16
Period of Report
2019-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qdel-201906308xk1.htm   iXBRL 8-K 53779
2 EXHIBIT 99.1 qdel-20190630exhibit991.htm EX-99.1 350652
8 qdel8k20image1a16.jpg GRAPHIC 11058
  Complete submission text file 0000353569-19-000048.txt   590912

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20190808.xsd EX-101.SCH 4660
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qdel-20190808_cal.xml EX-101.CAL 697
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20190808_def.xml EX-101.DEF 1547
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20190808_lab.xml EX-101.LAB 27263
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20190808_pre.xml EX-101.PRE 14187
9 EXTRACTED XBRL INSTANCE DOCUMENT qdel-201906308xk1_htm.xml XML 4515
Mailing Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-10961 | Film No.: 191009923
SIC: 2835 In Vitro & In Vivo Diagnostic Substances